Corium International Inc (CORI)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Peter D. Staple
Employees:
212
235 CONSTITUTION DRIVE, MENLO PARK, CA 94025
650-298-8012

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Corium International, Inc. is a commercial stage biopharmaceutical company, which develops, manufactures and commercializes of specialty pharmaceutical products. The company development platforms enable transdermal delivery of large molecules or biologics, including vaccines, peptides and proteins, as well as small molecules that are otherwise difficult to deliver in a transdermal dosage form. Corium International was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1995 and is headquartered in Menlo Park, CA.

Data derived from most recent annual or quarterly report
Market Cap 459.653 Million Shares Outstanding36.25 Million Avg 30-day Volume 631.053 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.21
Price to Revenue7.958 Debt to Equity2.8285 EBITDA-41.348 Million
Price to Book Value11.665 Operating Margin-125.31859999999999 Enterprise Value278.249 Million
Current Ratio7.61 EPS Growth0.11 Quick Ratio7.387
1 Yr BETA 0.9684 52-week High/Low 0.0 / Profit Margin-155.2114
Operating Cash Flow Growth-24.4849 Altman Z-Score-1.4301 Free Cash Flow to Firm -32.404 Million

Are you looking for this stock instead?

View SEC Filings from CORI instead.

View recent insider trading info

Funds Holding CORI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CORI

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2018-11-27:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-11-15:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-10-11:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-05-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-03-16:
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
  • 8-K: filed on 2018-03-05:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
  • 8-K: filed on 2018-03-01:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-02-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-11-16:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-08-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    GREENWOOD DAVID

    • Director
    No longer subject to file 2018-11-27 0

    BJERKHOLT ERIC

    • Director
    No longer subject to file 2018-11-27 0

    GODDARD PAUL

    • Director
    No longer subject to file 2018-11-27 0

    GARDNER PHYLLIS

    • Director
    No longer subject to file 2018-11-27 0

    BREUIL ROBERT S CHIEF FINANCIAL OFFICER

    • Officer
    No longer subject to file 2018-11-27 0

    STAPLE PETER D PRESIDENT & CEO

    • Officer
    • Director
    No longer subject to file 2018-11-27 0

    THOMAS ROBERT

    • Director
    No longer subject to file 2018-11-27 0

    GERGEL IVAN P.

    • Director
    No longer subject to file 2018-11-27 0

    ESSEX WOODLANDS HEALTH VENTURES FUND VII LP

    • 10% Owner
    No longer subject to file 2018-11-27 0

    CHAUDHURI BHASKAR

    • Director
    No longer subject to file 2018-11-27 0

    SARRET JOSEPH J. CHIEF BUSINESS OFFICER

    • Officer
    No longer subject to file 2018-11-27 0

    BROADFIN HEALTHCARE MASTER FUND LTD

    BROADFIN CAPITAL, LLC

    KOTLER KEVIN

    • 10% Owner
    No longer subject to file 2018-11-27 0

    EASTMAN RONALD W

    • Director
    • 10% Owner
    No longer subject to file 2018-11-27 0

    SINGH PARMINDER CTO & VICE PRESIDENT, R&D

    • Officer
    No longer subject to file 2018-11-27 0

    SWEEMER TIMOTHY D CHIEF ACCOUNTING OFFICER

    • Officer
    No longer subject to file 2018-11-27 0

    GURNET HOLDING CO

    GURNET MERGER SUB, INC.

    GURNET POINT, L.P.

    WAYPOINT INTERNATIONAL GP LLC

    • 10% Owner
    100 2018-11-27 0

    PERCEPTIVE ADVISORS LLC

    PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

    EDELMAN JOSEPH

    • 10% Owner
    No longer subject to file 2018-10-11 0

    GURNET HOLDING CO

    GURNET MERGER SUB, INC.

    GURNET POINT, L.P.

    • 10% Owner
    0 2018-10-11 0

    KOZARICH JOHN W

    • Director
    0 2014-12-04 0

    CLEARY GARY W

    GARY W. CLEARY & NOBUKO SAITO CLEARY, TRUSTEES OF THE CLEARY-SAITO FAMILY TRUST U/D/T DATED SEPTEMBER 4, 1996

    • Director
    • 10% Owner
    290,402 2014-04-08 0

    WELCH DANIEL G

    • Director
    0 2014-04-02 0

    FAASSE ADRIAN

    • 10% Owner
    871,207 2014-04-02 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments